<DOC>
	<DOCNO>NCT01914939</DOCNO>
	<brief_summary>This 3-year study trial cognitive behavioral therapy ( CBT ) , without oxytocin ( OT ) augmentation , young adult autism spectrum disorder . Participants randomly assign receive either social skills-focused CBT intervention stress management/relaxation training CBT intervention . Participants also randomize receive either ) intranasal oxytocin b ) placebo drug , prior psychotherapy . The design study enable examination efficacy CBT young adult autism spectrum disorder . The design study also allow examination whether oxytocin enhances efficacy CBT . The investigator perform functional ( fMRI ) structural ( MRI ) image participant prior treatment . This enable examination relation measure brain function structure , improvement target symptoms course treatment . The aim discover whether neural characteristic identify participant autism spectrum disorder likely respond CBT intervention and/or oxytocin treatment .</brief_summary>
	<brief_title>A Randomized , Controlled Trial Intranasal Oxytocin Adjunct Behavioral Therapy Autism Spectrum Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Age 1840 Able attend person therapy session Boston Male Englishspeaking Normal correct vision No history know genetic disorder , significant motor developmental difficulty , prematurity brain injury IQ &gt; 90 , determine WASI Score cutoff Reciprocal Social Interactions Restricted , Repetitive , Stereotyped Behaviors Domains ADIR , meet criterion PDD autism ADOS , and/or meet DSMIV criterion Autism Spectrum Disorder accord clinician interview . Current use certain endocrinologically relevant medication Current dependence substance tobacco caffeine History serious medical illness , include neurological , endocrine , cardiac , respiratory , metabolic disease counterindications oxytocin Severe , current psychiatric disorder ( ie , current mania , severe depression , psychosis , suicidality , severe aggression ) Long QT , determine baseline EKG Current participation psychotherapy Additional exclusion criterion MRI scan : Participants MRIineligible enrol clinical trial portion study , undergo MRI scan MIT . Exclusion criterion MRI : Presence metal implant metal body History claustrophobia inability tolerate MRI</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>autism spectrum disorder</keyword>
	<keyword>social skill deficit</keyword>
	<keyword>cognitive behavioral therapy</keyword>
	<keyword>oxytocin</keyword>
	<keyword>young adult</keyword>
</DOC>